What is QTTB's P/E ratio?

Q32 Bio Inc (QTTB) currently trades at a P/E ratio of 7.80.

Q32 Bio Inc reports a Return on Equity (ROE) of 71.78%.

What is QTTB's dividend yield?

Q32 Bio Inc offers a dividend yield of 0.00%.

What is QTTB's Quality Score?

Our AI rates QTTB's overall financial quality at 69 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy QTTB?

Our AI Timing Score for QTTB is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does QTTB belong to?

Q32 Bio Inc is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Q32 Bio Inc (QTTB) Stock Price, Quality Score & AI Analysis

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

QTTB AI Analysis Summary

Our AI summary for QTTB: Q32 Bio Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 7.80, ROE of 71.78%, a dividend yield of 0.00%. Its financial Quality Score stands at 69/100 — mid-range fundamentals relative to the market. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

QTTB

Q32 Bio Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 98

USD 16.16

0.99 (6.53%) Day Change

Watchlist Portfolio Compare Chart

7.80

P/E

0.19

D/E

71.8%

ROE

52.2%

ROA

0.00%

Div Yield

Q32 BIO INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 16.16 Price 0.99 (6.53%) Day Change	NEWS SCORE: 98

QTTB, the overall quality is ok ( Quality = 69) and the timing to buy is ...(Sign In to See)...

Loading chart...

69 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...

Quality Factors

57%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	98
Magic Formula Rank by ROA	96 GOOD
Magic Formula Rank by ROE	96 GOOD
Magic Formula Rank by ROIC	105
Price	16.16
PBV / Sector	9.73 / 44,022.72
Earning Per Share	1.19

PE / Sector	7.80 / 19.17 GREAT
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	47.34 M GREAT
Average 1W Daily Value	8.28 M

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

68%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	61.86 / 98.24 GREAT
NPM Average (%) / Sector	70.44 / -1,697.63 GREAT
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	52.21 / 185,260.96 GREAT
ROA Average (%) / Sector	-26.94 / 36,684.70
ROA Change Average (%) / Sector	-43.79 / 422,221.66
ROE (%) / Sector	71.78 / 243,762.23 GREAT
ROE Average (%) / Sector	-138.61 / 48,758.47
ROE Change Average (%) / Sector	-823.07 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 08:00:45
Symbol	QTTB
Name	Q32 BIO INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	29.71 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	450.53 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 830 Winter Street, Waltham, MA, United States, 02451

Phone: 781 999 0232

Website: https://www.q32bio.com

Sector: Healthcare >> Biotechnology

Description: Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.